Impact of Insulin Resistance on Silent and Ongoing Myocardial Damage in Normal Subjects: The Takahata Study

Table 2

Comparisons of clinical characteristics of patients with and without IR.

	IR (−)	IR (+)	Mets
Age	63 ± 10	63 ± 10	63 ± 10
Male	659 (46.2%)	169 (33.2%)*	145 (54.9%)^*#
BMI	21.9 ± 2.8	24.4 ± 3.2*	26.1 ± 2.5^*#
sBP	132 ± 16	136 ± 15*	134 ± 14*
dBP	78 ± 10	80 ± 10*	84 ± 8^*#
BNP (pg/mL)	21.5 (12.1–37.4)	17.1 (9.5–30.5)*	17.5 (9.4–33.6)*
TC (g/dL)	197 (177–217)	204 (187–226)*	205 (182–229)*
TG (g/dL)	81 (63–106)	101 (77–128)*	171 (150–224)^*#
HDL (g/dL)	61 ± 14	58 ± 13*	46 ± 12^*#
LDL (g/dL)	122 ± 29	131 ± 28*	124 ± 30^*#
eGFR (mL/min/1.73 m^2)	97 (82–112)	98 (83–111)	86 (74–102)^*#
H-FABP (ng/mL)	3.5 (2.6–4.6)	3.6 (2.6–4.7)*	3.7 (2.8–5.1)*

BMI: body mass index; BNP: brain natriuretic peptide; TC: total cholesterol; TG: triglyceride; HDLc: high density lipoprotein cholesterol; LDLc: low density lipoprotein cholesterol; H-FABP: heart type fatty acid binding protein; sBP: systolic blood pressure; dBP: diastolic blood pressure; Data are presented as mean ± S.D or median (interquartile range). *P < 0.05 versus IR (−); ^#P < 0.05 versus IR (+).